Author: Courtellemont, L.; Guinard, J.; Guillaume, C.; Giaché, S.; Rzepecki, V.; Seve, A.; Gubavu, C.; Baud, K.; Le Helloco, C.; Cassuto, G. N.; Pialoux, G.; Hocqueloux, L.; Prazuck, T.
Title: High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARSâ€CoVâ€2 infection Cord-id: wik2vwfb Document date: 2021_3_1
ID: wik2vwfb
Snippet: The severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2) pandemic has become a major public health issue worldwide. Developing and evaluating rapid and easyâ€toâ€perform diagnostic tests is a high priority. The current study was designed to assess the diagnostic performance of an antigenâ€based rapid detection test (COVIDâ€VIRO(®)) in a realâ€life setting. Two nasopharyngeal specimens of symptomatic or asymptomatic adult patients hospitalized in the Infectious Diseases Departme
Document: The severe acute respiratory syndrome coronavirus 2 (SARSâ€CoVâ€2) pandemic has become a major public health issue worldwide. Developing and evaluating rapid and easyâ€toâ€perform diagnostic tests is a high priority. The current study was designed to assess the diagnostic performance of an antigenâ€based rapid detection test (COVIDâ€VIRO(®)) in a realâ€life setting. Two nasopharyngeal specimens of symptomatic or asymptomatic adult patients hospitalized in the Infectious Diseases Department or voluntarily accessing the COVIDâ€19 Screening Department of the Regional Hospital of Orléans, France, were concurrently collected. The diagnostic specificity and sensitivity of COVID VIRO® results were compared to those of realâ€time reverseâ€transcriptase quantitative polymerase chain reaction (RTâ€qPCR) results. A subset of patients underwent an additional oropharyngeal and/or saliva swab for rapid testing. A total of 121 patients confirmed to be infected and 127 patients having no evidence of recent or ongoing infection were enrolled for a total of 248 nasopharyngeal swab specimens. Overall, the COVIDâ€VIRO® sensitivity was 96.7% (CI, 93.5%–99.9%). In asymptomatic patients, symptomatic patients having symptoms for more than 4 days and those with an RTâ€qPCR cycle threshold value ≥ 32, the sensitivities were 100%, 95.8%, and 91.9%, respectively. The concordance between RTâ€qPCR and COVID VIRO® rapid test results was 100% for the 127 patients with no SARSâ€CoVâ€2 infection. The COVIDâ€VIRO® test had 100% specificity and sensitivity greater than 95%, which are better than the recommendations set forth by the WHO (specificity ≥ 97%–100%, sensitivity ≥ 80%). These rapid tests may be particularly useful for largeâ€scale screening in emergency departments, lowâ€resource settings, and airports.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date